DaVita Shares Outstanding 2010-2024 | DVA
DaVita shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- DaVita shares outstanding for the quarter ending September 30, 2024 were 0.086B, a 8.77% decline year-over-year.
- DaVita 2023 shares outstanding were 0.093B, a 2.77% decline from 2022.
- DaVita 2022 shares outstanding were 0.096B, a 12.84% decline from 2021.
- DaVita 2021 shares outstanding were 0.11B, a 10.34% decline from 2020.
DaVita Annual Shares Outstanding
(Millions of Shares) |
| 2023 |
93 |
| 2022 |
96 |
| 2021 |
110 |
| 2020 |
123 |
| 2019 |
154 |
| 2018 |
172 |
| 2017 |
191 |
| 2016 |
205 |
| 2015 |
216 |
| 2014 |
217 |
| 2013 |
215 |
| 2012 |
196 |
| 2011 |
193 |
| 2010 |
206 |
| 2009 |
208 |
DaVita Quarterly Shares Outstanding
(Millions of Shares) |
| 2024-09-30 |
86 |
| 2024-06-30 |
89 |
| 2024-03-31 |
91 |
| 2023-12-31 |
93 |
| 2023-09-30 |
94 |
| 2023-06-30 |
93 |
| 2023-03-31 |
92 |
| 2022-12-31 |
96 |
| 2022-09-30 |
93 |
| 2022-06-30 |
98 |
| 2022-03-31 |
101 |
| 2021-12-31 |
110 |
| 2021-09-30 |
110 |
| 2021-06-30 |
111 |
| 2021-03-31 |
114 |
| 2020-12-31 |
123 |
| 2020-09-30 |
124 |
| 2020-06-30 |
124 |
| 2020-03-31 |
127 |
| 2019-12-31 |
154 |
| 2019-09-30 |
151 |
| 2019-06-30 |
167 |
| 2019-03-31 |
167 |
| 2018-12-31 |
172 |
| 2018-09-30 |
167 |
| 2018-06-30 |
174 |
| 2018-03-31 |
182 |
| 2017-12-31 |
191 |
| 2017-09-30 |
191 |
| 2017-06-30 |
194 |
| 2017-03-31 |
195 |
| 2016-12-31 |
205 |
| 2016-09-30 |
207 |
| 2016-06-30 |
208 |
| 2016-03-31 |
208 |
| 2015-12-31 |
216 |
| 2015-09-30 |
217 |
| 2015-06-30 |
218 |
| 2015-03-31 |
213 |
| 2014-12-31 |
217 |
| 2014-09-30 |
217 |
| 2014-06-30 |
217 |
| 2014-03-31 |
216 |
| 2013-12-31 |
215 |
| 2013-09-30 |
215 |
| 2013-06-30 |
215 |
| 2013-03-31 |
214 |
| 2012-12-31 |
196 |
| 2012-09-30 |
193 |
| 2012-06-30 |
192 |
| 2012-03-31 |
191 |
| 2011-12-31 |
193 |
| 2011-09-30 |
190 |
| 2011-06-30 |
195 |
| 2011-03-31 |
197 |
| 2010-12-31 |
206 |
| 2010-09-30 |
208 |
| 2010-06-30 |
209 |
| 2010-03-31 |
210 |
| 2009-12-31 |
208 |
| 2009-09-30 |
209 |
| 2009-06-30 |
208 |
| 2009-03-31 |
209 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$12.872B |
$12.140B |
|
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
|
